Aspirin may reduce risk of melanoma
Aspirin may help reduce a woman’s risk of the most dangerous type of skin cancer.
Researchers evaluated the use of pain relievers among nearly 60 thousand post-menopausal women over 12 years.
They found that post-menopausal women who used aspirin two or more times a week had a 21 percent lower risk of developing melanoma than women who did not take aspirin.
The researchers report other pain relievers, including ibuprofen, naproxen, and acetaminophen, did not lower the melanoma risk.